RA Capital Management’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History
Bought
Maintained
Sold
Other funds holding DALS
RA Capital Management's DALS Position: Q1 2023 in Review
RA Capital Management sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q1 2023, closing a stake of 1,500,000 shares — an estimated $15M sold.
RA Capital Management first reported a position in DALS in Q3 2021 and held it in 6 quarters. The position peaked at $15M in Q4 2022. 50 funds tracked by Wall St. Rank hold DALS as of Q1 2023.
- RA Capital Management reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q1 2023 after selling out during the quarter.
- RA Capital Management sold 1,500,000 DA32 Life Science Tech Acquisition Corp shares in Q1 2023, an estimated $15M.
- RA Capital Management first reported a position in DA32 Life Science Tech Acquisition Corp in Q3 2021 and held it in 6 quarters.
- RA Capital Management's DA32 Life Science Tech Acquisition Corp position peaked at $15M in Q4 2022.
- 50 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q1 2023.
Based on RA Capital Management's 13F filing for Q1 2023, filed 15 May 2023.